ABN Amro Investment Solutions raised its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 398,784 shares of the company's stock after purchasing an additional 48,682 shares during the quarter. Procter & Gamble accounts for about 0.8% of ABN Amro Investment Solutions' portfolio, making the stock its 28th biggest position. ABN Amro Investment Solutions' holdings in Procter & Gamble were worth $57,150,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently modified their holdings of the company. Triodos Investment Management BV grew its holdings in Procter & Gamble by 7.3% during the third quarter. Triodos Investment Management BV now owns 255,095 shares of the company's stock valued at $39,195,000 after purchasing an additional 17,400 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company's stock worth $36,050,992,000 after acquiring an additional 1,419,322 shares during the period. Strengthening Families & Communities LLC boosted its holdings in shares of Procter & Gamble by 820.6% in the third quarter. Strengthening Families & Communities LLC now owns 14,803 shares of the company's stock worth $2,308,000 after acquiring an additional 13,195 shares during the period. Heritage Wealth Management Inc. boosted its holdings in shares of Procter & Gamble by 32.7% in the third quarter. Heritage Wealth Management Inc. now owns 150,814 shares of the company's stock worth $23,173,000 after acquiring an additional 37,198 shares during the period. Finally, Gradient Investments LLC boosted its holdings in shares of Procter & Gamble by 12.8% in the fourth quarter. Gradient Investments LLC now owns 253,089 shares of the company's stock worth $36,270,000 after acquiring an additional 28,777 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. Evercore set a $162.00 price objective on Procter & Gamble in a research report on Monday, April 27th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $163.00 price target on shares of Procter & Gamble in a report on Monday, April 27th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Procter & Gamble in a report on Friday, March 27th. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating for the company in a report on Thursday, April 23rd. Finally, Dbs Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating in a report on Friday, January 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average price target of $161.06.
Read Our Latest Stock Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CEO Ma. Fatima Francisco sold 5,549 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $165.29, for a total transaction of $917,194.21. Following the transaction, the chief executive officer directly owned 1,029 shares of the company's stock, valued at approximately $170,083.41. This trade represents a 84.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.20% of the company's stock.
Procter & Gamble Stock Up 0.9%
Shares of NYSE PG opened at $142.59 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market cap of $332.02 billion, a P/E ratio of 20.85, a PEG ratio of 6.06 and a beta of 0.41. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $170.99. The firm has a 50-day simple moving average of $145.36 and a two-hundred day simple moving average of $148.02.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, topping analysts' consensus estimates of $1.56 by $0.03. The business had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $1.54 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.1%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date of this dividend was Friday, April 24th. Procter & Gamble's dividend payout ratio is 63.60%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.